Investigation of Factors Affecting Recovery Time Following a Single Dose of Rocuronium

Investigation of Factors Affecting Recovery Time Following a Single Dose of Rocuronium - Investigation of Factors Affecting Recovery Time Following a Single Dose of Rocuronium

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000055225

Enrollment

100

Registered

2024-08-12

Start date

2024-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Men and women aged 18 and over

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients undergoing general anesthesia in whom the administration of muscle relaxants and their antagonists is possible.

Exclusion criteria

Exclusion criteria: 1) Patients with drug allergies to rocuronium, propofol, or sugammadex 2) Patients undergoing surgeries where the administration of muscle relaxants or muscle relaxant antagonists is not desirable 3) Patients using medications that may affect the action of muscle relaxants or their antagonists (e.g., anticonvulsants, female hormone preparations) 4) Other patients deemed unsuitable as study subjects by the principal or sub-investigator [Rationale for Criteria] 1), 2), 4) Considerations for safety; 3) Considerations for potential impacts on efficacy evaluation.

Design outcomes

Primary

Measure	Time frame
TOF Count 1 Recovery Time of Muscle Relaxants.	—

Countries

Japan

Contacts

Public ContactTAKAHIRO SUGIURA

Kimitsu central hospital Anesthesiology

sugiura.takahiro@navy.plala.or.jp0438361071

Outcome results